Need To Know: Analysts Are Much More Bullish On Astera Labs, Inc. (NASDAQ:ALAB) Revenues

Celebrations may be in order for Astera Labs, Inc. (NASDAQ:ALAB) shareholders, with the analysts delivering a significant upgrade to their statutory estimates for the company. The analysts have sharply increased their revenue numbers, with a view that Astera Labs will make substantially more sales than they’d previously expected. The market may be pricing in some blue sky too, with the share price gaining 29% to US$231 in the last 7 days. It will be interesting to see if today’s upgrade is enough to propel the stock even higher.

We’ve found 21 US stocks that are forecast to pay a dividend yield of over 6% next year. See the full list for free.

Following the upgrade, the current consensus from Astera Labs’ 24 analysts is for revenues of US$3.4b in 2027 which – if met – would reflect a substantial 118% increase on its sales over the past 12 months. Statutory earnings per share are presumed to soar 103% to US$5.36. Prior to this update, the analysts had been forecasting revenues of US$3.0b and earnings per share (EPS) of US$4.87 in 2027. The most recent forecasts are noticeably more optimistic, with a solid increase in revenue estimates and a lift to earnings per share as well.

Check out our latest analysis for Astera Labs

Despite these upgrades, the consensus price target fell 11% to US$344, perhaps signalling that the uplift in performance is not expected to last.

These estimates are interesting, but it can be useful to paint some more broad strokes when seeing how forecasts compare, both to the Astera Labs’ past performance and to peers in the same industry. The period to the end of 2027 brings more of the same, according to the analysts, with revenue forecast to display 86% growth on an annualised basis. That is in line with its 76% annual growth over the past three years. By contrast, our data suggests that other companies (with analyst coverage) in a similar industry are forecast to see their revenues grow 26% per year. So it’s pretty clear that Astera Labs is forecast to grow substantially faster than its industry.

The Bottom Line

The most important thing to take away from this upgrade is that analysts upgraded their earnings per share estimates for next year, expecting improving business conditions. Fortunately, analysts also upgraded their revenue estimates, and our data indicates sales are expected to perform better than the wider market. Furthermore, there was a cut to the price target, suggesting that the latest news has led to more pessimism about the intrinsic value of the business. Seeing the dramatic upgrade to next year’s forecasts, it might be time to take another look at Astera Labs.

Analysts are clearly in love with Astera Labs at the moment, but before diving in – you should be aware that we’ve identified some warning flags with the business, such as concerns around earnings quality. For more information, you can click through to our platform to learn more about this and the 2 other warning signs we’ve identified .

Another way to search for interesting companies that could be reaching an inflection point is to track whether management are buying or selling, with our free list of growing companies backed by insiders.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.